NowPatient Review

NowPatient: an all-brand GLP-1 route with a free consult and no markup on the drug

NowPatient is unusual in a market that runs on compounded copies. It's a US-UK telehealth platform, headquartered in Austin, that prescribes only FDA-approved brand-name weight-management medicines — Mounjaro, Wegovy as both an injection and an oral tablet, and Saxenda. The pitch is simple and, refreshingly, honest about its own economics: the consultation is free, and you pay only for the cost of the medication itself. If you specifically want the real, branded drug and not a pharmacy-compounded version, NowPatient is built for you. If you came here hunting for the cheapest possible monthly price, this is almost certainly not your provider.

How the pricing actually works: free visit, brand list price for the drug

There is no membership, no program fee, and no consult charge. NowPatient's own FAQ states it plainly: 'the consultation itself is completely free,' and if a clinician prescribes medication, 'you only pay for the cost of the medication.' The catch is that the medication is the full branded product, so your out-of-pocket effectively tracks each manufacturer's cash list price. In practice that starts around $1069 a month for Mounjaro and climbs to a high three-figure-to-low-four-figure range for Wegovy and Saxenda.

To put that in perspective, the category median monthly price across the providers we track is about $169 — a figure built largely on compounded semaglutide and tirzepatide. NowPatient sits many multiples above that line, not because it marks the drug up, but because brand-name GLP-1s simply cost what they cost when you pay cash. You're trading price for the brand.

The medication catalog — and the rare oral Wegovy option

NowPatient's verified weight-management lineup covers three molecules: tirzepatide as Mounjaro, semaglutide as Wegovy, and liraglutide as Saxenda. The standout is that Wegovy is offered in both the familiar weekly injection and the newer oral tablet — one of the few places you'll find the pill version at all. For people who genuinely dread needles, that's a real, concrete reason to look here rather than at a compounding-only clinic.

• Mounjaro (tirzepatide injection) — typically the lowest monthly cost of the four
• Wegovy injection (semaglutide) — the standard weekly pen
• Wegovy oral tablet (semaglutide) — the needle-free pill, rarely offered elsewhere
• Saxenda (liraglutide injection) — an older daily-injection option

What genuinely sets NowPatient apart

Two things. First, it is all-brand by design — there is no compounded semaglutide or tirzepatide anywhere in the catalog. Every drug you can get is the FDA-approved product straight from the manufacturer, which removes the formulation-quality and sourcing questions that hang over the compounded market. Second, it doesn't pad the bill: no markup on the medicine, no consult fee, no monthly platform charge. The price you see is essentially the drug's own price, and the visit that gets you there costs nothing. That combination — brand-only plus zero markup — is genuinely uncommon.

Who should choose it, and who should skip it

Choose NowPatient if you want the real branded drug, value a transparent fee structure, or specifically need the oral Wegovy tablet. It also suits people who plan to use insurance or a manufacturer savings card against a brand prescription, since you're holding a legitimate brand-name script rather than a compounded one.

Skip it if budget is your top priority. Compounded semaglutide and tirzepatide from other providers usually land a fraction of the cost, and paying brand list price out of pocket is a heavy lift for most people. A few practical frictions matter too: NowPatient doesn't publish which states it serves — that's sorted during intake, not shown upfront — and it doesn't carry Foundayo (orforglipron), so the newer oral options outside the Wegovy tablet aren't on the menu.

Trust, safety, and medical oversight

On the safety ledger, NowPatient looks clean. There are no FDA warning letters on file for this provider, and because it dispenses only approved brand-name medication, there's no compounding pharmacy partner whose accreditation you'd need to scrutinize. The free-consultation model is clinician-gated — a prescriber has to write the script before you pay for anything. Our main caveat is transparency around logistics: the published state list and any shipping terms are thin on the US side, so confirm coverage for your state and your total delivered cost during the free intake before you commit. You can see how we weigh these factors in our scoring methodology.

Bottom line

NowPatient is a clean, honest, brand-only GLP-1 provider for people who want the genuine article and a no-fee path to it — and it's one of the only places offering Wegovy as a pill. Just go in clear-eyed: starting near $1069 a month and ranging higher for Wegovy and Saxenda, you're paying full brand price. If that's the trade you want, NowPatient makes it about as straightforward and markup-free as brand-name GLP-1 access gets. If you'd rather save money with a compounded route, look elsewhere.

For a side-by-side, Brightmeds ($325/month) and bmiMD ($99/month) are the most comparable options to weigh against NowPatient.